Alpha 1-Antitrypsin Deficiency Clinical Trials in Auckland
2 recruitingAuckland, New Zealand
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
Alpha 1-Antitrypsin Deficiency
Beam Therapeutics Inc.106 enrolled11 locationsNCT06389877
Recruiting
Phase 2
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
EmphysemaAlpha 1-Antitrypsin Deficiency
Sanofi185 enrolled40 locationsNCT05897424